G1 Therapeutics

5 email addresses found for g1therapeutics.com
{last}@g1therapeutics.com
5 email addresses
http://apnews.com/071e64eccc3f0bfbb288642b7565c448 October 10, 2018
http://apnews.com/1c2552cd7add25f98df060715cc11cf9 October 10, 2018
http://apnews.com/52d34bbbd1074d7f239f66c34a708550 October 10, 2018
http://hatterasvp.com/g1-therapeutics-announces-pricing-of-offering-of-common-stock August 8, 2018
http://hatterasvp.com/g1-therapeutics-expands-executive-leadership-team-with-appointment-of-john-demaree-as-chief-commercial-officer-and-stillman-hanson-as-general-counsel August 8, 2018
http://health.einnews.com/pr_news/447319955/g1-therapeutics-to-present-phase-1b-data-on-g1t38-in-combination-with-faslodex-for-treatment-of-breast-cancer-at-2018-american-society-of-clinical October 10, 2018
http://lumiraventures.com/g1-therapeutics-announces-appointment-of-new-members-to-the-board-of-directors August 8, 2018
http://lumiraventures.com/g1-therapeutics-announces-closing-of-offering-of-common-stock August 8, 2018
http://lumiraventures.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-benefits-in-patients-with-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-expands-executive-leadership-team-with-appointment-of-john-demaree-as-chief-commercial-officer-and-stillman-hanson-as-general-counsel August 8, 2018
http://mtngp.com/g1-therapeutics-announces-initiation-of-phase-1b-2-clinical-trial-of-g1t38-in-combination-with-tagrisso-for-egfr-mutant-non-small-cell-lung-cancer July 7, 2018
http://mtngp.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer April 4, 2018
http://ptcommunity.com/wire/g1-therapeutics-present-phase-1b-data-g1t38-combination-faslodex-treatment-breast-cancer-2018 September 9, 2018
http://unique.finance/g1-therapeutics-presents-phase-1b-data-on-g1t38-in-combination-with-faslodex-for-treatment-of-breast-cancer-at-2018-american-society-of-clinical-oncology-asco-annual-meeting June 6, 2018
http://cnbc.com/2015/02/05/globe-newswire-g1-therapeutics-raises-33-million-in-series-b-financing.html July 7, 2018
http://cnbc.com/2015/05/13/globe-newswire-g1-therapeutics-to-present-new-data-on-cdk46-inhibitor-g1t28-at-the-2015-american-society-of-clinical-oncology-annual.html March 3, 2018
http://cnbc.com/2015/05/27/globe-newswire-g1-therapeutics-announces-positive-phase-1a-data-for-cdk46-inhibitor-g1t28.html March 3, 2018
http://cnbc.com/2015/10/21/globe-newswire-glenn-p-muir-appointed-to-g1-therapeutics-board-of-directors.html March 3, 2018
http://cnbc.com/2016/02/02/globe-newswire-g1-therapeutics-to-present-at-the-18th-annual-bio-ceo-investor-conference.html March 3, 2018
http://g1therapeutics.com/pages/news/releases/031615.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/040815.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/041515.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/052715.htm June 6, 2015
http://g1therapeutics.com/pages/news/releases/061015.htm June 6, 2015
http://hatterasvp.com/g1-therapeutics-raises-33-million-in-series-b-financing May 5, 2016
http://hatterasvp.com/g1-therapeutics-secures-47-million-series-c-financing May 5, 2016
http://hatterasvp.com/g1-therapeutics-to-evaluate-trilaciclib-g1t28-in-combination-with-immune-checkpoint-inhibitor-in-small-cell-lung-cancer January 1, 2017
http://life-sciences-europe.com/news/therapeutics-raises-million-series-inc-nasdaq-gthx-medimmune-2001-110998.html October 10, 2017
http://life-sciences-europe.com/news/therapeutics-secures-million-series-inc-nasdaq-gthx-cormorant-2001-110999.html October 10, 2017
http://lumiraventures.com/g1-therapeutics-announces-initiation-of-two-phase-1b2a-trials-of-cdk46-inhibitor-g1t28-in-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-secures-47-million-series-c-financing August 8, 2018
http://lumiraventures.com/g1-therapeutics-to-evaluate-trilaciclib-g1t28-in-combination-with-immune-checkpoint-inhibitor-in-small-cell-lung-cancer August 8, 2018
http://lumiraventures.com/g1-therapeutics-to-present-positive-clinical-and-preclinical-data-on-cdk46-inhibitor-g1t28 August 8, 2018
http://lumiraventures.com/glenn-p-muir-appointed-to-g1-therapeutics-board-of-directors August 8, 2018
http://mgcfund.com/g1-therapeutics-secures-47-million-series-c-financing July 7, 2016
http://mtngp.com/g1-therapeutics-announces-presentations-2017-american-association-cancer-research-annual-meeting April 4, 2018
http://mtngp.com/g1-therapeutics-initiates-three-drug-development-programs-breast-cancer March 3, 2017
http://mtngp.com/g1-therapeutics-secures-47-million-series-c-financing November 11, 2016

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about g1therapeutics.com

Language of the website: English

Main technologies used: